Effect of antihypertensive treatment on circulating endothelial progenitor cells in patients with mild essential hypertension

Blood Pressure

Volumn 20, Issue 2, 2011, Pages 77-83

  De Ciuceis, Carolina ^a   Pilu, Annamaria ^a   Rizzoni, Damiano ^a   Porteri, Enzo ^a   Muiesan, Maria Lorenza ^a   Salvetti, Massimo ^a   Paini, Anna ^a   Belotti, Eugenia ^a   Zani, Francesca ^a   Boari, Gianluca E M ^a   Rosei, Claudia Agabiti ^a   Rosei, Enrico Agabiti ^a  

^a UNIVERSITY OF BRESCIA   (Italy)

Author keywords

Barnidipine; endothelial function; endothelial progenitor cells; endothelium; hydrochlorothiazide; hypertension

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROCHLOROTHIAZIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEPIRODIPINE; POTASSIUM; TRIACYLGLYCEROL;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR RISK; CELL COUNT; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG EFFECT; ENDOTHELIAL PROGENITOR CELL; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION;

ADULT; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; ENDOTHELIAL CELLS; FEMALE; HUMANS; HYDROCHLOROTHIAZIDE; HYPERTENSION; MALE; MIDDLE AGED; NIFEDIPINE; STEM CELLS;

EID: 79952767171     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.3109/08037051.2010.535973     Document Type: Article

References (46)

1. Ross R. The pathogenesis of atherosclerosis - An update. N Engl J Med. 1986;314:488-500.
2. Deanfield JE, Halcox JP, Rabelink TJ. Endothelial function and dysfunction: Testing and clinical relevance. Circulation. 2007;115:1285-1295. (Pubitemid 46594773)
3. Lerman A, Zeiher AM. Endothelial function: Cardiac events. Circulation. 2005;1111:363-368. (Pubitemid 40165345)
4. Drexler H. Endothelial dysfunction: Clinical implications. Prog Cardiovasc Dis. 1997;39:287-324. (Pubitemid 27120399)
5. Widlansky MR, Gokce N, Keaney JF, Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol. 2003;42:1149-1160. (Pubitemid 37188333)
6. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967. (Pubitemid 27087709)
7. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999;85:221-228. (Pubitemid 29377293)
8. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
9. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med. 2003;348:593-600. (Pubitemid 36204953)
10. Quyyumi AA, Hill JM. Circulating endothelial progenitor cells as novel biological determinants of vascular function and risk. Can J Cardiol. 2004;20 Suppl B:44B-48B.
11. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, et al. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation. 2005;111:2981-2987. (Pubitemid 40814192)
12. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med. 2005;353:999-1007. (Pubitemid 41262334)
13. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, et al. HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001;108:391-397. (Pubitemid 32730785)
14. Bahlmann FH, de Groot K, Mueller OH, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells - A new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension. 2005;45:526-529. (Pubitemid 40411254)
15. Min TQ, Zhu CJ, Xiang WX, Hui ZJ, Peng SY. Improvement in endothelial progenitor cells from peripheral blood by ramipril therapy in patients with stable coronary artery disease. Cardiovasc Drugs Ther. 2004;18:203-209. (Pubitemid 38918955)
16. Sugiura T, Kondo T, Kureishi-Bando Y, Numaguchi Y, Yoshida O, Dohi Y, et al. Nifedipine improves endothelial function: Role of endothelial progenitor cells. Hypertension. 2008;52:491-498.
17. Delva P, Degan M, Vallerio P, Arosio E, Minuz P, Amen G, et al. Endothelial progenitor cells in patients with essential hypertension. J Hypertens. 2007;25:127-132. (Pubitemid 44885673)
18. Guidelines Committee. 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
19. Rizzoni D, Porteri E, Castellano M, Bettoni G, Muiesan ML, Tiberio G, et al. Endothelial dysfunction in hypertension is independent from the etiology and from vascular structure. Hypertension. 1998;31(part 2):335-341.
20. Muiesan ML, Salvetti M, Monteduro C, Rizzoni D, Zulli R, Corbellini C, et al. Effect of treatment on flow-dependent vasodilation of the brachial artery in essential hypertension. Hypertension. 1999;33(Part II):575-580. (Pubitemid 29065723)
21. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 1990;323:22-27. (Pubitemid 20209468)
22. Iiyama K, Nagano M, Yo Y, Nagano N, Kamide K, Higaki J, et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J. 1996;132:779-782. (Pubitemid 26366976)
23. Mizuno Y, Jacob RF, Mason RP. Effects of calcium channel and renin-angiotensin system blockade on intravascular and neurohormonal mechanisms of hypertensive vascular disease. Am J Hypertens. 2008;21:1076-1085.
24. Schiffrin EL, Pu Q, Park JB. Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients. Am J Hypertens. 2002, 15(2 Part 1):105-110. (Pubitemid 34161083)
25. Taddei S, Virdis A, Ghiadoni L, Uleri S, Magagna A, Salvetti A. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients. Hypertension. 1997;30:1606-1612. (Pubitemid 27528112)
26. Ganafa AA, Walton M, Eatman D, Abukhalaf IK, Bayorh MA. Amlodipine attenuates oxidative stress-induced hypertension. Am J Hypertens. 2004;17:743-748. (Pubitemid 39201087)
27. Taddei S, Virdis A, Ghiadoni L, Magagna A, Favilla S, Pompella A, et al. Restoration of nitric oxide availability after calcium antagonist treatment in essential hypertension. Hypertension. 2001;37:943-948. (Pubitemid 32221618)
28. Wassmann S, Hilgers S, Laufs U, Böhm M, Nickenig G. Angiotensin II type 1 receptor antagonism improves hypercholesterolemia associated endothelial dysfunction. Arterioscler Thromb Vasc Biol. 2002;22:1208-1212. (Pubitemid 34764875)
29. Zhou MS, Schulman IH, Jaimes EA, Raij L. Thiazide diuretics, endothelial function, and vascular oxidative stress. J Hypertens. 2008;26:494-500. (Pubitemid 351317258)
30. Schiffrin EL, Deng LY. Structure and function of resistance arteries of hypertensive patients treated with a beta blocker or a calcium channel antagonist. J Hypertens. 1996;14:1237-1244.
31. Ghiadoni L, Magagna A, Versari D, Kardasz I, Huang Y, Taddei S, et al. Different effect of antihypertensive drugs on conduit artery endothelial function. Hypertension. 2003;41:1281-1286. (Pubitemid 36706078)
32. Junhui Z, Xingxiang W, Guosheng F, Yunpeng S, Furong Z, Junzhu C. Reduced number and activity of circulating endothelial progenitor cells in patients with idiopathic pulmonary arterial hypertension. Respir Med. 2008;102:1073-1079.
33. Imanishi T, Hano T, Nishio I. Angiotensin II potentiates vascular endothelial growth factor-induced proliferation and network formation of endothelial progenitor cells. Hypertens Res. 2004;27:101-108. (Pubitemid 38331920)
34. Berkels R, Egink G, Marsen TA, Bartels H, Roesen R, Klaus W. Nifedipine increases endothelial nitric oxide bioavailability by antioxidative mechanisms. Hypertension. 2001;37:240-245. (Pubitemid 32199081)
35. Yu Y, Fukuda N, Yao EH, Matsumoto T, Kobayashi N, Suzuki R, et al. Effects of an ARB on endothelial progenitor cell function and cardiovascular oxidation in hypertension. Am J Hypertens. 2008;21:72-77.
36. Malhotra HS, Plosker GL. Barnidipine. Drugs. 2001;61:989-996.
37. Spirou A, Rizos E, Liberopoulos EN, Kolaitis N, Achimastos A, Tselepis AD, et al. Effect of barnidipine on blood pressure and serum metabolic parameters in patients with essential hypertension: A pilot study. J Cardiovasc Pharmacol Ther. 2006;11:256-261. (Pubitemid 44936239)
38. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004;109 (23 suppl 1):III15-III19.
39. Kasiske BL, Ma JZ, Kalil RSN, Louis TA. Effects of antihypertensive therapy on serum lipids. Ann Intern Med. 1995;122:133-141.
40. Brook RD. Mechanism of differential effects of antihypertensive agents on serum lipids. Curr Hypertens Rep. 2000;2:370-377.
41. Leonetti G. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: A double blind, prospective, randomized clinical trial. Curr Med Res Opin. 2005;21:951-958. (Pubitemid 40896243)
42. Nandeesha H, Pavithran P, Madanmohan T. Effect of antihypertensive therapy on serum lipids in newly diagnosed essential hypertensive men. Angiology. 2009;60:217-220.
43. Neutel JM. Metabolic manifestations of low-dose diuretics. Am J Med. 1996;101:71S-82S.
44. Lithell H. Hypertension and hyperlipidemia. Am J Hypertens. 1993;6:303S-308S.
45. Schmidt-Lucke C, Fichtlscherer S, Rössig L, Kämper U, Dimmeler S. Improvement of endothelial damage and regeneration indexes in patients with coronary artery disease after 4 weeks of statin therapy. Atherosclerosis. 2010;211:249-254.
46. G iannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, Horvàth T, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension. Relation to endothelial dysfunction. Hypertension. 2010;55:1389-1397.